Middlefield Limited · TSX
| Assets under management | $154.77M |
|---|---|
| Expense ratio | — |
| Category | — |
| Dividend yield | 2.56% |
| NAV | $12.07 |
| Fund family | Middlefield Limited |
| Exchange | TSX |
The largest positions Middlefield Healthcare Dividend ETF reports, by weight.
| Holding | Name | Weight |
|---|---|---|
| LLY | Eli Lilly and Co | 7.26% |
| JNJ | Johnson & Johnson | 6.52% |
| ABBV | AbbVie Inc | 5.31% |
| MRK | Merck & Co Inc | 4.71% |
| AZN.L | AstraZeneca PLC | 4.03% |
| TMO | Thermo Fisher Scientific Inc | 3.81% |
| SYK | Stryker Corp | 3.03% |
| DHR | Danaher Corp | 2.76% |
| NOVN.SW | Novartis AG Registered Shares | 2.73% |
| UNH | UnitedHealth Group Inc | 2.67% |